Patents Assigned to JointTechLabs, Inc.
  • Patent number: 11447748
    Abstract: A therapeutic composition comprising a purified fraction of adipose-derived mesenchymal stem cells encapsulated in a three-dimensional biocompatible gel matrix, and methods, and systems for preparing and using encapsulated adipose-derived mesenchymal stem cells. Hydrogel microbeads encapsulating stem cells maintain the viability and location of the stem cells for an extended period as compared to stem cells in suspension. The gel matrix allows the release of cellular factors from the encapsulated stem cells to surrounding tissues to achieve desired therapeutic results.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: September 20, 2022
    Assignee: JointTechLabs, Inc.
    Inventors: Nathan Katz, Felix Pustilnik
  • Publication number: 20200370017
    Abstract: A therapeutic composition comprising a purified fraction of adipose-derived mesenchymal stem cells encapsulated in a three-dimensional biocompatible gel matrix, and methods, and systems for preparing and using encapsulated adipose-derived mesenchymal stem cells. Hydrogel microbeads encapsulating stem cells maintain the viability and location of the stem cells for an extended period as compared to stem cells in suspension. The gel matrix allows the release of cellular factors from the encapsulated stem cells to surrounding tissues to achieve desired therapeutic results.
    Type: Application
    Filed: August 14, 2020
    Publication date: November 26, 2020
    Applicant: JointTechLabs, Inc.
    Inventors: Nathan Katz, Felix Pustilnik
  • Publication number: 20190224245
    Abstract: A device that allows for either fat graft preparation or cell fraction harvest is disclosed. The device includes a first centrifuge tube configured to receive and process a biological substance, the first centrifuge tube comprising an upper cylindrical portion and a lower conical portion, a sterile tissue inlet fitting, at least one sterile processing fluid inlet fitting, a sterile suction fitting, and at least one sterile extraction port connected to a first extraction tube. The first centrifuge tube further includes an internal space including a screen being positioned therein, the screen being configured to divide the internal space in half, and a filter positioned therein, the filter being positioned below the screen in the lower conical portion of the first centrifuge tube. The device may further include a second centrifuge tube configured to receive and further process the biological substance from the first centrifuge tube.
    Type: Application
    Filed: April 2, 2019
    Publication date: July 25, 2019
    Applicant: JointTechLabs, Inc.
    Inventors: Nathan Katz, Nishit Pancholi